JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 4,390.00
-60.00 (-1.35%)
Jul 20, 2026, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 163.69 billion as of July 20, 2026. Its market cap has decreased by -34.97% in one year.
Market Cap
163.69B
Enterprise Value
274.11B
Revenue
77.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,390.00
ChartMarket Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 163.69B, an increase of 26.79%. That is a compound annual growth rate of 3.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 163.69B | -25.72% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 265.95B |
| BINEX | 214.65B |
| EASY BIO,Inc. | 208.09B |
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| Helixmith | 160.93B |
| Bioneer | 160.02B |